阿里健康(00241.HK)与拜耳订立战略合作协议 惟股价逆市续跌4.5%至逾半年低
阿里健康(00241.HK)与德国药厂拜耳订立战略合作协议,但大和及汇丰昨天分别下调阿里健康目标价17.7%至27元及13.4%至29元,前者反映下调今明两年盈测,後者反映其毛利率逊预期。该股连跌第三天,最低见19.3元,创逾半年低,现造19.34元,跌4.5%,成交2,045万股,涉资逾4亿元。
阿里健康公布,与德国药企拜耳签订战略合作协议,双方将重点探索抗凝类药物的患者管理业务,并将在药品新零售、患者教育、在线医药服务等领域展深开度合作。同时,依托於阿里健康领域生态布局、自营链路及仓配体系,双方并将在互联网医院项目、药品新零售业务进行合作,探索线上处方流转新模式,以期实现慢病患者的线上服务及全程管理,并计划共建药品业务品牌旗舰店,为患者提供更好的医药服务。
恒指今早在金融股带动高开逾百点,在建行(00939.HK)、三大传统银行中银(02388.HK)、恒生(00011.HK)及随美债息率走高的汇控(00005.HK)依次升逾1%-2.5%支持,高见29,333遇压,曾回顺至29,098,现造29,227,回升114点或0.4%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.